Pharmacological disruption of the binding between progerin and lamin A/C using JH4, a small molecule that reduces the toxic effects of progerin accumulation and improves nuclear structure, has a beneficial effect on alleviating the symptoms of Hutchinson-Gilford progeria syndrome (HGPS)[99]. The gene discussed is LMNA; the disease is Hutchinson-Gilford progeria syndrome.